On the other hand, the higher expression of SERTAD1 showed better outcome outcomes in relapse free survival (44.4 as compared to low exp. 31) of breast cancer patients (RNA seq data set, n = 626, Logrank test p = 0.000032, HR = 0.72). This evidence concerns the gene SERTAD1 and breast carcinoma.